Wire Stories
-
742BeiGene Announces Positive Topline Results from Phase 3 Trial of Tislelizumab in Combination with Chemotherapy as First-Line Treatment for Recurrent or Metastatic Nasopharyngeal Cancer
Tislelizumab combined with chemotherapy demonstrated a statistically significant improvement in progression-free survival at the interim analysis Safety findings of tislelizumab were consistent...
-
696
ESE Partners with Leading Research and Data Analytics Company, Kantar, For Esports Research and Services
VANCOUVER, British Columbia, May 21, 2021 (GLOBE NEWSWIRE) — ESE Entertainment Inc. (�we�, �ESE�, or the �Company�) (TSXV: ESE) (OTCQB: ENTEF) is...
-
681
Anunta Named Winner of VMware 2021 APJ Partner Digital Transformation Award
Award Recognizes Partners for Providing Complete Solutions and Notable Business Outcomes in Advancing Their Customer’s Digital Transformation Journeys MANILA, Philippines–(BUSINESS WIRE)–#AnandaMukerji–Anunta today...
-
681
Global Major Depressive Disorder Drugs Markets Report 2021: Duloxetine, Escitalopram & Venlafaxine – Focus on US, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, Brazil – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Major Depressive Disorder Drugs Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Product Type” report...
-
560
MOGU to Report Fourth Quarter and Fiscal Year 2021 Financial Results on May 28, 2021
HANGZHOU, China–(BUSINESS WIRE)–MOGU Inc. (NYSE: MOGU) (�MOGU� or the “Company”), a leading KOL-driven online fashion and lifestyle destination in China, today announced...
-
525
East Asia Semiconductor Market Report 2021-2025: Market is Poised to Grow by $84.41 Billion with South Korea Driving growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Semiconductor Market in East Asia 2021-2025” report has been added to ResearchAndMarkets.com’s offering. The semiconductor market in East Asia is...
-
725
�U.S. Food & Drug Administration Grants Priority Review of Maribavir for the Treatment of Post-Transplant Recipients With Cytomegalovirus Infection in Those Resistant and/or Refractory to Prior Anti-CMV Treatment
�? If Approved, Maribavir Will Be the First and Only Treatment Indicated for Post-Transplant Cytomegalovirus (CMV) Infection in Those That Are Refractory,...
-
621
CORRECTING and REPLACING Meiji Seika Pharma: Promising Results of Phase I Clinical Trial of DMB-3115, a Proposed Ustekinumab Biosimilar, and Initiation of Phase III Clinical Trial in Patients With Plaque Psoriasis
TOKYO–(BUSINESS WIRE)–First paragraph, third sentence of release dated May 20, 2021, should read: Those clinical trials are conducted in collaboration with Dong-A...
-
640
Takeda Announces Approval of Moderna�s COVID-19 Vaccine in Japan
? The Ministry of Health, Labour and Welfare (MHLW) Grants Regulatory Approval of Moderna�s COVID-19 Vaccine (COVID-19 Vaccine Moderna Intramuscular Injection) Following...
-
682
Japan�s Ministry of Health, Labour and Welfare (MHLW) Approves Moderna�s COVID-19 Vaccine
Interim data from Takeda-led Phase 1/2 study indicates immune response consistent with Moderna�s Phase 3 COVE study Takeda will import and distribute...
